Status:

NOT_YET_RECRUITING

Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy

Lead Sponsor:

University of Sydney

Collaborating Sponsors:

National Health and Medical Research Council, Australia

Northern Sydney and Central Coast Area Health Service

Conditions:

Lung Neoplasm

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational validation study is to determine the best implementation of fluoroscopic and CT ventilation imaging in patients having non-stereotactic ablative body radiotherapy (non-S...

Detailed Description

Lung cancer is the leading cause of cancer mortality worldwide with non-small cell lung cancers (NSCLC) accounting for approximately 85% of all lung cancers diagnosed. Surgery, immunotherapy, chemothe...

Eligibility Criteria

Inclusion

  • Aged 18 years or older.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
  • Histologically proven Stage II-IV non-small cell lung cancer as determined using the IASLC International Association for the Study of Lung Cancer (IASLC) 8th edition lung cancer staging guidelines.
  • To be treated with curative intent (stage II-III) or palliative intent (stage IV) with non-SABR external beam radiotherapy (e.g. 60 Gy in 30 treatments for curative intent or 30 Gy in 5 treatments for palliative intent).
  • Pulmonary function tests within 8 weeks of registration.
  • 4DCT simulation for radiation therapy.
  • Willingness to give written informed consent.
  • Willingness and ability to comply with the study procedures and visit requirements.
  • Available for follow up for 1 year or until death, whichever occurs first.

Exclusion

  • Prior radiation therapy to the thorax.
  • Prior surgery for this cancer.
  • Prior chemotherapy for this cancer.
  • Interstitial lung disease.
  • Pregnant women.

Key Trial Info

Start Date :

July 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06159660

Start Date

July 1 2024

End Date

September 1 2026

Last Update

July 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal North Shore Hospital

St Leonards, New South Wales, Australia, 2065